Catalyst Wire Dossier Catalyst Wire Dossier

Ropeginterferon

ropeginterferon alfa-2b
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ropeginterferon, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) [Phase 1]

See pricing